circRNA basic information
circBase ID: hsa_circ_0000129
Name: hsa_circ_TMOD4
Synonym: circ_0000129
Host Gene: TMOD4
Genomic location(hg19): chr1:151145974-151149507:-
Genomic location(hg38): chr1:151173498-151177031:-
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007254
MONDO name: breast cancer
Disease details: breast cancer / BC
Disease DO ID:
1612
Disease MeSH ID:
-
Disease NCIt ID:
C9335
Disease ICD11 ID:
1047754165
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

breast cancer tissues; paired adjacent nontumor tissues; xenograft tumors

Cell lines:

MCF-7; MDA-MB-231; MCF-10A

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: EPSTI1
Associated microRNA: miR-578
Biological function: Relieves (attenuates) sevoflurane-induced suppression of breast cancer malignant behaviors by promoting proliferation, migration and invasion, and inhibiting apoptosis; partially reverses sevoflurane-induced tumor growth inhibition in vivo.
Molecular mechanism: ceRNA mechanism: circ_0000129 sponges miR-578 to regulate EPSTI1 expression, thereby modulating sevoflurane-mediated breast cancer progression.
Biological pathway or process:

proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); ceRNA regulation (other)

Detected method:
Q
Validation methods:

divergent primers PCR; RT-qPCR; Clinical Sample Validation; Luciferase Reporter Assay; RNA Pull-Down; Transfection; CCK8; EdU Staining; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry)

Clinical significance:

-

Description:

circ_0000129 is up-regulated in breast cancer tissues/cells and acts as a ceRNA that sponges miR-578 to increase EPSTI1 expression. Functionally, circ_0000129 counteracts sevoflurane’s anti-tumor effects by promoting proliferation, migration and invasion and reducing apoptosis, and it partially reverses sevoflurane-suppressed tumor growth in xenografts.

Confidence score:

0.7856

Other information
Title:

Sevoflurane suppresses the malignant progression of breast cancer via the hsa_circ_0000129/miR-578/EPSTI1 axis.

Journal: Thoracic cancer
Published: 2023
PubMed ID: 37533139
Study type:

combined biological and clinical study

Data availability: -
Code availability: -